MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202518007838 A) filed by Dose Medical Corporation on January 30, 2025, for Drug Eluting Ocular Implant With Retainer To Allow Elution Through The Membrane.
Inventors include Haffner, David; Curry, Ken; Heitzmann, Harold; and Applegate, David.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention relates to drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Disclaimer: Curated by HT Syndication.
